Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.37
17.06.21
€18.00
09.03.22
95.60%
10.03.22

Could be very worthwhile Investment >20% year
buy
Agilent Technologies Inc.

Start price
Target price
Perf. (%)
€101.00
09.03.21
€120.00
09.03.22
19.46%
10.03.22

Could be worthwhile Investment >10% per year
buy
Epizyme Inc.

Start price
Target price
Perf. (%)
€1.10
27.01.22
€1.00
27.01.23
41.00%
05.02.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
NanoVibronix Inc.

Start price
Target price
Perf. (%)
€52.08
13.08.21
€20.00
13.08.22
-65.13%
08.01.22

Probably not worthwhile Investment
Very low/no dividend yield expected
Little Investments for future growth
ROE lower than 10% per year
Biogen Inc.

Start price
Target price
Perf. (%)
€243.10
18.10.21
€210.00
02.01.23
-12.53%
16.12.21

Could be worthwhile Investment >10% per year
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€0.99
30.11.21
€1.00
30.11.22
36.36%
11.12.21

Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
Invitae Corp

Start price
Target price
Perf. (%)
€20.09
09.11.21
€17.00
31.12.23
-23.92%
01.12.21

Could be very worthwhile Investment >20% year
buy
Axonics Modulation Technologies Inc

Start price
Target price
Perf. (%)
€37.20
28.11.20
€42.00
28.11.21
31.72%
29.11.21

Could be worthwhile Investment >10% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
23.11.20
€555.00
23.11.21
29.97%
24.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

buy
Anavex Life Sciences Corp

Start price
Target price
Perf. (%)
€4.28
21.10.20
€6.00
04.11.21
348.60%
05.11.21

Could be worthwhile Investment >10% per year
buy
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€91.00
24.09.20
€145.00
04.11.21
114.29%
05.11.21

Could be worthwhile Investment >10% per year
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€13.13
25.08.20
€25.20
04.11.21
120.37%
05.11.21

Could be worthwhile Investment >10% per year
buy
Veracyte Inc.

Start price
Target price
Perf. (%)
€30.20
23.08.20
€45.00
04.11.21
49.01%
05.11.21

Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€2.66
13.08.20
€25.00
04.11.21
975.97%
05.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€131.66
06.06.20
€205.00
04.11.21
77.81%
05.11.21

Could be worthwhile Investment >10% per year
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€18.68
21.05.20
€30.00
04.11.21
531.06%
05.11.21

Could be worthwhile Investment >10% per year
buy
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€5.79
17.03.20
€15.00
04.11.21
200.79%
05.11.21

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€27.04
17.03.20
€33.21
04.11.21
47.75%
05.11.21

Could be worthwhile Investment >10% per year
buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€70.50
12.03.20
€145.00
04.11.21
119.55%
05.11.21

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.02
22.02.20
€33.21
04.11.21
28.78%
05.11.21

buy
Dexcom Inc.

Start price
Target price
Perf. (%)
€57.00
11.02.20
€78.75
04.11.21
137.81%
05.11.21

Could be worthwhile Investment >10% per year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€127.44
17.01.20
€160.00
04.11.21
83.69%
05.11.21

buy
Repligen Corp.

Start price
Target price
Perf. (%)
€87.50
12.01.20
€155.00
04.11.21
170.06%
05.11.21

Could be worthwhile Investment >10% per year